Watchlist Price Alert

Emergent BioSolutions Inc... (EBS)

NYSE: EBS · Real-Time Price · USD

6.26

-0.34 (-5.15%)

At close: Jun 13, 2025, 3:59 PM

6.40

2.24%

After-hours: Jun 13, 2025, 05:39 PM EDT

-5.15% (1D)

Bid	6.25
Market Cap	339.78M
Revenue (ttm)	960M
Net Income (ttm)	-131.6M
EPS (ttm)	-2.58
PE Ratio (ttm)	-2.43
Forward PE	5.28
Analyst	Buy

Ask	6.59
Volume	657,998
Avg. Volume (20D)	1,200,138
Open	6.40
Previous Close	6.60
Day's Range	6.18 - 6.46
52-Week Range	4.02 - 15.10
Beta	2.11

About EBS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol EBS

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for EBS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 month ago

+34.18%

Emergent BioSolutions shares are trading higher af... Unlock content with Pro Subscription

3 months ago

-8.69%

Emergent BioSolutions shares are trading lower after the company reported worse-than-expected Q4 revenue results.

News

2 weeks ago · zacks.com

5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost

Broker-favored picks like BYON, BTSG, ACDVF, EBS, and ADNT are worth monitoring amid EU tariff delay and rising consumer confidence.

4 weeks ago · zacks.com

5 Broker-Loved Stocks to Watch Amid Signs of Easing Trade Woes

Investors would do well to monitor broker-favored stocks like BTSG, BYON, ACDVF, DINO, and EBS for high returns.

1 month ago · seekingalpha.com

Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript

Emergent BioSolutions Inc. (NYSE:EBS ) Q1 2025 Earnings Call May 7, 2025 5:00 PM ET Company Participants Frank Vargo - Vice President, Assistant Treasurer Joe Papa - President and Chief Executive Offi...

1 month ago · zacks.com

Emergent Biosolutions (EBS) Q1 Earnings Top Estimates

Emergent Biosolutions (EBS) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.59 per share a year ago.